For RNF223, mutation sites have been related to age, International Federation of Gynecology and Obstetrics stage, and histology in sporadic and Lynch syndrome–associated endometrial cancer (Sun et al., 2021). This evidence concerns the gene RNF223 and endometrial cancer.